References
- Bentzen S.M., Overgaard J., Thames H.D., Overgaard M., Hansen P.V., von derMaase H., Meder J. Clinical radiobiology of malignant melanoma. Radiotherapy and Oncology 1989, In press
- de Boor C. A Practical Guide to Splines. Applied Mathematical Sciences. Springer-Verlag, New York 1978; 27
- Brahme A. Dosimetric precision requirements in radiation therapy. Acta Radiologica Oncology 1984; 23: 379–391
- Brock W.A., Maor M.H., Peters L.J. Predictors of tumor response to radiotherapy. Radiation Research 1985; 104(Suppl. 8)S290–S296
- Deacon J., Peckham M.J., Steel G.G. The radioresponsiveness of human tumors and the initial slope of the cell survival curve. Radiotherapy and Oncology 1984; 2: 317–323
- Diaconis P., Efron B. Computer-intensive methods in statistics. Scientific American May, 1983; 116–130
- Durand R.E. Repair during multifraction exposures: spheroids versus monolayers. British Journal of Cancer 1984; 49(Suppl. VI)203–206
- Durand R.E. Repair and proliferation: major determinants of the multifraction radiation response. International Journal of Radiation Oncology, Biology and Physics 1988; 15: 1147–1152
- Efron B. Bootstrap methods: another look at the jackknife. Annals of Statistics 1979; 7: 1–26
- Fertil B., Malaise E.P. Inherent radiosensitivity as a basic concept for human tumor radiotherapy. International Journal of Radiation Oncology, Biology and Physics 1981; 7: 621–629
- Fertil B., Malaise E.P. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. International Journal of Radiation Oncology, Biology and Physics 1985; 11: 1699–1707
- Hendry J.H., Moore J.V. Is the steepness of dose-incidence curves for tumour control or complications due to variation before, or as a result of, irradiation?. British Journal of Radiology 1984; 57: 1045–1046
- Hill R.P., Milas L. The proportion of stem cells in murine tumors. International Journal of Radiation Oncology, Biology and Physics 1989; 16: 513–518
- Munro T.R., Gilbert C.W. The relation between tumour lethal dose and the radiosensitivity of tumour cells. British Journal of Radiology 1961; 34: 246–251
- Overgaard J. The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 867–872
- Peters L.J., Brock W.A., Chapman J.D., Wilson G. Predictive assays of tumor radiocurability. American Journal of Clinical Oncology 1988; 11: 275–287
- Rockwell S. Effects of clumps and clusters on survival measurements with clonogenic assays. Cancer Research 1985; 45: 1601–1607
- Rofstad E.K. Radiation biology of malignant melanoma. Acta Radiologica Oncology 1986; 25: 1–10
- Rofstad E.K., Brustad T. Differential responses to radiation and hyperthermia of cloned cell lines derived from a single human melanoma xenograft. International Journal of Radiation Oncology, Biology and Physics 1984; 10: 857–864
- Rofstad E.K., Brustad T. Radioresponsiveness of human melanoma xenografts given fractionated radiotherapy in vivo—relationship to the initial slope of the cell survival curves in vitro. Radiotherapy and Oncology 1987; 9: 45–56
- Thames H.D., Withers H.R., Peters L.J., Fletcher G.H. Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationship. International Journal of Radiation Oncology, Biology and Physics 1982; 8: 219–226
- Tubiana M. The growth and progression of human tumors: implications for management strategy. Radiotherapy and Oncology 1986; 6: 167–184
- Tucker S.L., Thames H.D. The effect of patient-to-patient variability on the accuracy of predictive assays of tumor response to radiotherapy: a theoretical evaluation. International Journal of Radiation Oncology, Biology and Physics 1989; 17: 145–157
- Zagars G.K., Schultheiss T.E., Peters L.J. Inter-tumor heterogeneity and radiation dose-control curves. Radiotherapy and Oncology 1987; 8: 353–362